These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 7769190)

  • 1. Maintenance therapy in ulcerative colitis and Crohn's disease.
    Sachar DB
    J Clin Gastroenterol; 1995 Mar; 20(2):117-22. PubMed ID: 7769190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy of inflammatory bowel disease.
    Sack DM; Peppercorn MA
    Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-Aminosalicylic acid in ulcerative colitis and Crohn's disease (author's transl)].
    Maier K; Fischer C; Klotz U; Heinkel K
    Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1131-4. PubMed ID: 6123426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical therapies for ulcerative colitis and Crohn's disease.
    Baert FJ; Rutgeerts PJ
    Curr Gastroenterol Rep; 2000 Dec; 2(6):446-50. PubMed ID: 11079045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of symptomatic remission in patients with Crohn's disease.
    Stark ME; Tremaine WJ
    Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of mesalamine and nicotine in the treatment of inflammatory bowel disease.
    Bonapace CR; Mays DA
    Ann Pharmacother; 1997; 31(7-8):907-13. PubMed ID: 9220055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
    Kull E; Beau P
    Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
    Moum B
    Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug therapy of chronic inflammatory intestinal diseases].
    Raedler A; Reinecker C
    Immun Infekt; 1990 Aug; 18(4):121-6. PubMed ID: 2210794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
    Burakoff R
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S202-3. PubMed ID: 18816760
    [No Abstract]   [Full Text] [Related]  

  • 16. Review article: aminosalicylates in inflammatory bowel disease.
    Hanauer SB
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():60-5. PubMed ID: 15352896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of chronic inflammatory intestinal diseases--current status of 5-aminosalicylic acid].
    Schölmerich J; Gerok W
    Wien Klin Wochenschr; 1986 Nov; 98(22):762-9. PubMed ID: 2880425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Fischbach W
    Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term therapy in ulcerative colitis and Crohn's disease].
    Malchow H
    Fortschr Med; 1979 Aug; 97(29):1253-60. PubMed ID: 457018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.